-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Upgrades Qiagen to Overweight, Raises Price Target to $42

Benzinga·06/23/2026 17:36:39
Listen to the news
Morgan Stanley analyst Steve Beuchaw upgrades Qiagen (NYSE:QGEN) from Equal-Weight to Overweight and raises the price target from $40 to $42.